GINKGO BIOWORKS HOLDINGS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8601 USD | +10.60% |
|
-0.55% | -49.11% |
Chart calendar Ginkgo Bioworks Holdings, Inc.
eb4ab79d36bd7d5a7136b6d9973e1.PDqk-EwNhQnbtPTJ6luxl1Xg0CsKr3cznbm7BPeEyc4.aVeQv2Fm5kCeg7-iqTCHrxyHg0Iy-i9VyM_kQcbWvJsOWfCBLz7JZ4zgoQ~eadf51d00712c10099abd18f5adf53e9
Upcoming events on Ginkgo Bioworks Holdings, Inc.
Past events on Ginkgo Bioworks Holdings, Inc.
| 2024-03-05 14:10 | TD Cowen Health Care Conference |
| 2024-02-29 17:30 | Q4 2023 Earnings Call |
| 2024-02-29 17:01 | Q4 2023 Earnings Release |
| 2024-01-10 12:45 | JPMorgan Healthcare Conference |
| 2023-11-08 17:30 | Q3 2023 Earnings Call |
| 2023-11-08 17:01 | Q3 2023 Earnings Release |
| 2023-10-03 10:00 | Investor Day |
| 2023-09-13 12:55 | Morgan Stanley Global Healthcare Conference |
| 2023-08-15 17:00 | UBS MedTech Tools and Genomics Summit |
| 2023-08-09 17:30 | Q2 2023 Earnings Call |
| 2023-08-09 17:01 | Q2 2023 Earnings Release |
| 2023-06-16 16:00 | Annual General Meeting |
| 2023-06-12 19:40 | Goldman Sachs Global Healthcare Conference |
| 2023-05-18 15:00 | American Society of Gene Cell Therapy Meeting - Abstract #858 |
| 2023-05-10 16:30 | Q1 2023 Earnings Call |
| 2023-05-10 16:01 | Q1 2023 Earnings Release |
| 2023-03-06 16:40 | Cowen Health Care Conference - Panel |
| 2023-03-06 09:10 | Cowen Health Care Conference |
| 2023-03-01 16:30 | Q4 2022 Earnings Call |
| 2023-03-01 16:01 | Q4 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 314 250 25.36% | 478 472 1.31% | 251 259 -2.81% | 223 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -106 -142 25.54% | -173 -182 5.2% | -355 -392 9.36% | -405 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -1 828 -185 -888.68% | -2 209 -2 361 6.45% | -864 -832 -3.86% | -654 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -1 838 -297 -518.76% | -2 121 -2 296 7.6% | -893 -837 -6.66% | -631 |
|
Net income Million USD | Released Forecast Spread | -127 | -1 830 -301 -507.08% | -2 105 -2 324 9.44% | -893 -837 -6.64% | -631 |
|
EPS USD | Released Forecast Spread | -16,2 | -1,35 -0,19 -595.16% | -1,25 -1,42 12.13% | -0,46 -0,44 -4.55% | -0,32 |
| Announcement Date | 14/05/21 | 28/03/22 | 01/03/23 | 29/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 148 94,9 56.53% | 168 106 59.38% | 145 77,6 86.34% | 66,4 60,4 9.87% | 98,3 88,9 10.6% | 80,7 71,7 12.49% | 80,6 71,5 12.66% | 55,4 48,1 15.32% | 34,8 42,6 -18.32% | 46,0 | 53,2 | 58,7 | 65,2 | 66,3 |
|
EBITDA Million USD | Released Forecast Spread | 0,56 -32,0 101.76% | -1,95 -146 98.66% | -23,3 -48,3 51.67% | -69,6 73,1 -195.25% | -80,2 -78,4 -2.3% | -100 -69,2 -44.5% | -75,5 -83,7 9.84% | -83,8 -104 19.22% | -95,8 -131 27.01% | -92,1 | -89,9 | -89,4 | -87,4 | -86,5 |
|
EBIT Million USD | Released Forecast Spread | -1 685 -39,4 -4177.77% | -675 -184 -266.29% | -647 -408 -58.56% | -653 -462 -41.34% | -235 -307 23.62% | -216 -147 -47.1% | -184 -172 -7.28% | -286 -165 -73.44% | -178 -157 -13.7% | -168 | -164 | -163 | -163 | -147 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -1 606 -64,7 -2381.73% | -593 -243 -144.24% | -671 -282 -137.64% | -669 -349 -91.52% | -189 -273 30.75% | -205 -145 -40.86% | -173 -144 -20.48% | -303 -152 -99.61% | -212 -136 -55.8% | -169 | -167 | -167 | -165 | -154 |
|
Net income Million USD | Released Forecast Spread | -1 601 -71,5 -2137.88% | -591 -283 -108.5% | -669 -326 -105.17% | -669 -410 -63.38% | -177 -343 48.46% | -205 -159 -28.65% | -173 -165 -5.16% | -303 -164 -85.19% | -212 -136 -55.77% | -162 | -157 | -157 | -160 | -154 |
|
EPS USD | Released Forecast Spread | -1,05 -0,05 -2110.53% | -0,37 -0,17 -114.49% | -0,41 -0,14 -201.47% | -0,41 -0,21 -97.59% | -0,10 -0,21 51.61% | -0,11 -0,09 -25% | -0,09 -0,09 -1.89% | -0,16 -0,09 -88.24% | -0,11 -0,10 -13.79% | -0,08 | -0,08 | -0,08 | -0,08 | -0,08 |
| Announcement Date | 28/03/22 | 16/05/22 | 15/08/22 | 14/11/22 | 01/03/23 | 10/05/23 | 09/08/23 | 08/11/23 | 29/02/24 | - | - | - | - | - |
More events
Past sector events for Ginkgo Bioworks Holdings, Inc.
| 2024-04-26 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-26 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-26 01:00 | BB BIOTECH AG: Q1 2024 Earnings Release |
| 2024-04-25 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-25 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-25 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 07:00 | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 2024-04-25 02:00 | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- DNA Stock
- Calendar Ginkgo Bioworks Holdings, Inc.
